Trial Profile
A Phase III, Multicenter, Randomized, Two-arm Clinical Study: An Investigational Arm Containing Nimotuzumab in Combination with Radiation Therapy and Cisplatin, and A Control Arm with Radiation Therapy and Cisplatin for the Treatment of Stages IIb to IVa Uterine Cervical Carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin
- Indications Adenocarcinoma; Adenosquamous carcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms NICOL
- Sponsors Eurofarma
- 16 Feb 2014 New trial record